Task: Answer the multiple choice question.
Question: Which drug exhibits a -3.675\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CC(C)[C@@]1(c2ccccc2)ON(c2ccccc2C(F)(F)F)C1=O
b.) COC(=O)Cc1ccc(NC(=O)c2ccc3c(c2)C(=O)N(Cc2ccco2)C3=O)cc1
Answer: a. CC(C)[C@@]1(c2ccccc2)ON(c2ccccc2C(F)(F)F)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)[C@@]1(c2ccccc2)ON(c2ccccc2C(F)(F)F)C1=O
CC(C)[C@@]1(c2ccccc2)ON(c2ccccc2C(F)(F)F)C1=O
(4S)-4-phenyl-4-propan-2-yl-2-[2-(trifluoromethyl)phenyl]oxazetidin-3-one